Description
Seeking men and women with metastatic non-small cell lung cancer with high PD-L1 that has not previously been treated for a study comparing an investigational drug to the usual treatment.
Overview
Participants in this study will be randomly assigned to get either the investigational drug or the usual treatment. The infusions will be given in 21 day cycles for up to 2 years.
What we're hoping for
We are studying if an investigational drug is better, the same, or worse than the usual treatment for metastatic non-small cell lung cancer with high PD-L1 that has not previously been treated.
Additional Information
ClinicalTrials.gov Identifier: NCT06767514